{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:03:09Z","timestamp":1784815389083,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.taap.2026.117787","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:19:55Z","timestamp":1773361195000},"page":"117787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ophiopogonin B inhibits triple-negative breast cancer progression via suppressing PTP1B and regulating the PI3K\/Akt pathway"],"prefix":"10.1016","volume":"511","author":[{"given":"Yan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.117787_bb0005","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.taap.2026.117787_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2026.117787_bb0015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3892\/or.2012.2131","article-title":"Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K\/Akt signaling pathway","volume":"29","author":"Chen","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2026.117787_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7150\/jca.66432","article-title":"Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1\/GSDMD dependent pyroptosis","volume":"13","author":"Cheng","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.taap.2026.117787_bb0025","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12173","article-title":"Ophiopogonin B induces reactive oxygen species-dependent apoptosis through the Hippo pathway in nasopharyngeal carcinoma","volume":"24","author":"Dong","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2026.117787_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102305","article-title":"Uncarboxylated osteocalcin induced miR-143-3p targets SP7 and activates PI3K\/Akt signaling in TNBC cells to promote invasion and migration","volume":"53","author":"Du","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.taap.2026.117787_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157434","article-title":"Resveratrol impairs insulin signaling in hepatic cells via activation of PKC and PTP1B pathways","volume":"26","author":"Hern\u00e1ndez-Gonz\u00e1lez","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117787_bb0040","first-page":"717","article-title":"PTPN1 promotes the progression of glioma by activating the MAPK\/ERK and PI3K\/AKT pathways and is associated with poor patient survival","volume":"42","author":"Jin","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2026.117787_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28155804","article-title":"Natural-product-derived adjunctive treatments to conventional therapy and their immunoregulatory activities in triple-negative breast cancer","volume":"28","author":"Kan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2026.117787_bb0050","article-title":"PI3K\/Akt inhibition promotes AR activity and prostate cancer cell proliferation through p35-CDK5 modulation","volume":"1871","author":"Kao","year":"2025","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2026.117787_bb0055","article-title":"Natural products as novel therapeutic agents for triple-negative breast cancer: current evidence, mechanisms, challenges, and opportunities","volume":"30","author":"Li","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2026.117787_bb0060","article-title":"Triterpenes of Prunella vulgaris inhibit triple-negative breast cancer by regulating PTP1B\/PI3K\/AKT\/mTOR and IL-24\/CXCL12\/CXCR4 pathways","volume":"26","author":"Li","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117787_bb0065","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1038\/s41467-023-40170-8","article-title":"A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity","volume":"14","author":"Liang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2026.117787_bb0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.canlet.2015.01.020","article-title":"PTP1B promotes cell proliferation and metastasis through activating src and ERK1\/2 in non-small cell lung cancer","volume":"359","author":"Liu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2026.117787_bb0075","doi-asserted-by":"crossref","first-page":"1496511","DOI":"10.3389\/fphar.2025.1496511","article-title":"Anti-TNBC effects of Lappaol F by targeting epithelial-mesenchymal transition via regulation of GSK-3\u03b2\/YAP\/\u03b2-catenin and PI3K\/AKT pathways","volume":"16","author":"Meng","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.117787_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge","volume":"8","author":"Nedeljkovi\u0107","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.taap.2026.117787_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5483\/BMBRep.2017.50.3.189","article-title":"Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells","volume":"50","author":"Oh","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.taap.2026.117787_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157173","article-title":"Oleandrin-mediated suppression of MELK induces apoptosis, autophagy, and ferroptosis in human non-small cell lung cancer cells","volume":"147","author":"Omer","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.taap.2026.117787_bb0095","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1158\/0008-5472.CAN-18-4055","article-title":"Chemotherapy-induced extracellular vesicle miRNAs promote breast cancer stemness by targeting ONECUT2","volume":"79","author":"Shen","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2026.117787_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186035","article-title":"LIN28B-mediated PI3K\/AKT pathway activation promotes metastasis in colorectal cancer models","volume":"135","author":"Shin","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2026.117787_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108296","article-title":"Discovery of novel oleanolic acid glycoside derivatives targeting PTP1B\/PI3K\/AKT signaling pathway for the treatment of breast cancer","volume":"157","author":"Song","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.taap.2026.117787_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156287","article-title":"Cyclovirobuxine D inhibits triple-negative breast cancer via YAP\/TAZ suppression and activation of the FOXO3a\/PINK1-Parkin pathway-induced mitophagy","volume":"136","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.taap.2026.117787_bb0115","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-21-0694","article-title":"PTP1B is an intracellular checkpoint that limits T-cell and CAR T-cell antitumor immunity","volume":"12","author":"Wiede","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.taap.2026.117787_bb0120","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41419-019-2073-4","article-title":"Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2\/AMPK\/mTOC1 pathway","volume":"10","author":"Xu","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2026.117787_bb0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.taap.2026.117787_bb0130","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/febs.14724","article-title":"PTP1B markedly promotes breast cancer progression and is regulated by miR-193a-3p","volume":"286","author":"Yu","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.taap.2026.117787_bb0135","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2022.12638","article-title":"Ophiopogonin-B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K\/AKT and AMPK signaling pathways","volume":"25","author":"Yuan","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2026.117787_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114706","article-title":"The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: an investigation using network pharmacology-based analysis","volume":"283","author":"Yuan","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2026.117787_bb0145","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.3892\/mmr.2016.5198","article-title":"Effects of ophiopogonin B on the proliferation and apoptosis of SGC-7901 human gastric cancer cells","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2026.117787_bb0150","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.7150\/jca.60066","article-title":"Ophiopogonin B inhibits migration and invasion in non-small cell lung cancer cells through enhancing the interaction between Axin and \u03b2-catenin","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.taap.2026.117787_bb0155","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3892\/ol.2022.13224","article-title":"Ophiopogonin B induces gastric cancer cell death by blocking the GPX4\/xCT-dependent ferroptosis pathway","volume":"23","author":"Zhang","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.taap.2026.117787_bb0160","doi-asserted-by":"crossref","first-page":"2432098","DOI":"10.1080\/15384047.2024.2432098","article-title":"Liu-Shen-Wan inhibits PI3K\/Akt and TRPV1 signaling alleviating bone cancer pain in rats","volume":"25","author":"Zhang","year":"2024","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.taap.2026.117787_bb0165","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jare.2025.01.035","article-title":"Ailanthone induces triple-negative breast cancer cells death involving the inhibition of OTUB1-mediated ERR\u03b1 deubiquitylation","volume":"77","author":"Zhang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.taap.2026.117787_bb0170","first-page":"221","article-title":"Cancer incidence and mortality in China, 2022","volume":"46","author":"Zheng","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:18:26Z","timestamp":1784812706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"alternative-id":["S0041008X26000839"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117787","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ophiopogonin B inhibits triple-negative breast cancer progression via suppressing PTP1B and regulating the PI3K\/Akt pathway","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117787"}}